Prolia® Clinical Trials
3 recruitingDrug
Phase 32Phase 41
Showing 1–3 of 3 trials
Recruiting
Phase 4
A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China
Glucocorticoid-induced Osteoporosis
Amgen100 enrolled16 locationsNCT06588153
Recruiting
Phase 3
A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®
Postmenopausal Women With Osteoporosis at High Risk of Fracture
Qilu Pharmaceutical Co., Ltd.278 enrolled1 locationNCT07062978
Recruiting
Phase 3
A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis
Postmenopausal Women Osteoporosis
Mabwell (Shanghai) Bioscience Co., Ltd.278 enrolled1 locationNCT06804590